New York University Abu Dhabi (NYUAD), Yas Clinic- Khalifa city, and Abu Dhabi Stem Cells Centre (ADSCC) have announced a ...

For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of ...

The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis ...

Common shrews are one of only a handful of mammals known to flexibly shrink and regrow their brains. This rare seasonal cycle, known as Dehnel's phenomenon, has puzzled scientists for decades. How can ...

The actress, who was diagnosed with the autoimmune disease in 2018, reveals to Parade, 'I still have some glitches.' ...

New Novartis data further support benefits of Kesimpta in relapsing MS following switch from oral disease modifying therapies: Basel Thursday, September 25, 2025, 15:00 Hrs [IST] ...

Drs Anne Cross and Scott Newsome discuss new horizons in MS treatment strategies, including the TREAT-MS trial and shared ...

Li-Fraumeni syndrome (LFS) is a high-risk hereditary cancer predisposition syndrome affecting 1 in 5000 individuals. Current ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New ...